The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meyer-Siegler, K. L.
Right arrow Articles by Vera, P. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meyer-Siegler, K. L.
Right arrow Articles by Vera, P. L.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
Medline Plus Health Information
*Prostate Cancer
The Journal of Immunology, 2006, 177: 8730-8739.
Copyright © 2006 by The American Association of Immunologists, Inc.

Inhibition of Macrophage Migration Inhibitory Factor or Its Receptor (CD74) Attenuates Growth and Invasion of DU-145 Prostate Cancer Cells1

Katherine L. Meyer-Siegler2,*,{dagger}, Kenneth A. Iczkowski{ddagger},§, Lin Leng, Richard Bucala and Pedro L. Vera*,{dagger}

* The Bay Pines Veterans Affairs Healthcare System, Research and Development, Bay Pines, FL 33744; {dagger} University of South Florida, Department of Surgery, Tampa, FL 33612; {ddagger} Malcom Randall Veterans Affairs Medical Center, Department of Pathology, Gainesville, FL 32608; § University of Florida College of Medicine, Department of Pathology, Immunology, and Laboratory Medicine, Gainesville, FL 32610; and Yale University School of Medicine, New Haven, CT 06520

Macrophage migration inhibitory factor (MIF), a proinflammatory cytokine, is overexpressed in prostate cancer, but the mechanism by which MIF exerts effects on tumor cells remains undetermined. MIF interacts with its identified membrane receptor, CD74, in association with CD44, resulting in ERK 1/2 activation. Therefore, we hypothesized that increased expression or surface localization of CD74 and MIF overexpression by prostate cancer cells regulated tumor cell viability. Prostate cancer cell lines (LNCaP and DU-145) had increased MIF gene expression and protein levels compared with normal human prostate or benign prostate epithelial cells (p < 0.01). Although MIF, CD74, and CD44 variant 9 expression were increased in both androgen-dependent (LNCaP) and androgen-independent (DU-145) prostate cancer cells, cell surface of CD74 was only detected in androgen-independent (DU-145) prostate cancer cells. Therefore, treatments aimed at blocking CD74 and/or MIF (e.g., inhibition of MIF or CD74 expression by RNA interference or treatment with anti-MIF- or anti-CD74- neutralizing Abs or MIF-specific inhibitor, ISO-1) were only effective in androgen-independent prostate cancer cells (DU-145), resulting in decreased cell proliferation, MIF protein secretion, and invasion. In DU-145 xenografts, ISO-1 significantly decreased tumor volume and tumor angiogenesis. Our results showed greater cell surface CD74 in DU-145 prostate cancer cells that bind to MIF and, thus, mediate MIF-activated signal transduction. DU-145 prostate cancer cell growth and invasion required MIF activated signal transduction pathways that were not necessary for growth or viability of androgen-dependent prostate cells. Thus, blocking MIF either at the ligand (MIF) or receptor (CD74) may provide new, targeted specific therapies for androgen-independent prostate cancer.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Supported by Veterans Affairs Merit Review Program (to K.L.M.-S. and P.L.V.), the Bay Pines Foundation (to K.L.M.-S. and P.L.V.), and National Institutes of Health (to R.B. and L.L.).

2 Address correspondence and reprint requests to Dr. Katherine L. Meyer-Siegler, Bay Pines Veterans Affairs Health Care System, Research and Development (151), 10000 Bay Pines Boulevard, Bay Pines, FL 33744. E-mail address: Katherine.Siegler{at}med.va.gov

3 Abbreviations used in this paper: MIF, macrophage inhibitory factor; CD44v9, CD44 variant 9; PrEC, human prostate epithelial cells; PVDF, polyvinylidene difluoride; RNAi, RNA interference; PCNA, proliferating cell nuclear Ag; p-ERK, phosphorylated ERK; pNA, p-nitroaniline.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. Piette, M. Deprez, T. Roger, A. Noel, J.-M. Foidart, and C. Munaut
The Dexamethasone-induced Inhibition of Proliferation, Migration, and Invasion in Glioma Cell Lines Is Antagonized by Macrophage Migration Inhibitory Factor (MIF) and Can Be Enhanced by Specific MIF Inhibitors
J. Biol. Chem., November 20, 2009; 284(47): 32483 - 32492.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Honda, R. Abe, Y. Yoshihisa, T. Makino, K. Matsunaga, J. Nishihira, H. Shimizu, and T. Shimizu
Deficient deletion of apoptotic cells by macrophage migration inhibitory factor (MIF) overexpression accelerates photocarcinogenesis
Carcinogenesis, September 1, 2009; 30(9): 1597 - 1605.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T. Oda, T. Tian, M. Inoue, J.-i. Ikeda, Y. Qiu, M. Okumura, K. Aozasa, and E. Morii
Tumorigenic Role of Orphan Nuclear Receptor NR0B1 in Lung Adenocarcinoma
Am. J. Pathol., September 1, 2009; 175(3): 1235 - 1245.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
R. Leth-Larsen, R. Lund, H. V. Hansen, A.-V. Laenkholm, D. Tarin, O. N. Jensen, and H. J. Ditzel
Metastasis-related Plasma Membrane Proteins of Human Breast Cancer Cells Identified by Comparative Quantitative Mass Spectrometry
Mol. Cell. Proteomics, June 1, 2009; 8(6): 1436 - 1449.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Merk, J. Baugh, S. Zierow, L. Leng, U. Pal, S. J. Lee, A. D. Ebert, Y. Mizue, J. O. Trent, R. Mitchell, et al.
The Golgi-Associated Protein p115 Mediates the Secretion of Macrophage Migration Inhibitory Factor
J. Immunol., June 1, 2009; 182(11): 6896 - 6906.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
G. Fingerle-Rowson, D. R. Kaleswarapu, C. Schlander, N. Kabgani, T. Brocks, N. Reinart, R. Busch, A. Schutz, H. Lue, X. Du, et al.
A Tautomerase-Null Macrophage Migration-Inhibitory Factor (MIF) Gene Knock-In Mouse Model Reveals That Protein Interactions and Not Enzymatic Activity Mediate MIF-Dependent Growth Regulation
Mol. Cell. Biol., April 1, 2009; 29(7): 1922 - 1932.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
L. M. Marsh, L. Cakarova, G. Kwapiszewska, W. von Wulffen, S. Herold, W. Seeger, and J. Lohmeyer
Surface expression of CD74 by type II alveolar epithelial cells: a potential mechanism for macrophage migration inhibitory factor-induced epithelial repair
Am J Physiol Lung Cell Mol Physiol, March 1, 2009; 296(3): L442 - L452.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. McClelland, L. Zhao, S. Carskadon, and D. Arenberg
Expression of CD74, the Receptor for Macrophage Migration Inhibitory Factor, in Non-Small Cell Lung Cancer
Am. J. Pathol., February 1, 2009; 174(2): 638 - 646.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y.-H. Liu, C.-Y. Lin, W.-C. Lin, S.-W. Tang, M.-K. Lai, and J.-Y. Lin
Up-Regulation of Vascular Endothelial Growth Factor-D Expression in Clear Cell Renal Cell Carcinoma by CD74: A Critical Role in Cancer Cell Tumorigenesis
J. Immunol., November 1, 2008; 181(9): 6584 - 6594.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Winner, J. Meier, S. Zierow, B. E. Rendon, G. V. Crichlow, R. Riggs, R. Bucala, L. Leng, N. Smith, E. Lolis, et al.
A Novel, Macrophage Migration Inhibitory Factor Suicide Substrate Inhibits Motility and Growth of Lung Cancer Cells
Cancer Res., September 15, 2008; 68(18): 7253 - 7257.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. M. Coleman, B. E. Rendon, M. Zhao, M.-W. Qian, R. Bucala, D. Xin, and R. A. Mitchell
Cooperative Regulation of Non-Small Cell Lung Carcinoma Angiogenic Potential by Macrophage Migration Inhibitory Factor and Its Homolog, D-Dopachrome Tautomerase
J. Immunol., August 15, 2008; 181(4): 2330 - 2337.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J.-i. Ikeda, E. Morii, Y. Liu, Y. Qiu, N. Nakamichi, R. Jokoji, Y. Miyoshi, S. Noguchi, and K. Aozasa
Prognostic Significance of CD55 Expression in Breast Cancer
Clin. Cancer Res., August 1, 2008; 14(15): 4780 - 4786.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. E. Armstrong, M. Gantier, L. Li, W. Y. Chung, A. McCann, J. A. Baugh, and S. C. Donnelly
Small Interfering RNAs Induce Macrophage Migration Inhibitory Factor Production and Proliferation in Breast Cancer Cells via a Double-Stranded RNA-Dependent Protein Kinase-Dependent Mechanism
J. Immunol., June 1, 2008; 180(11): 7125 - 7133.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
W. D. Culp, P. Tsagozis, M. Burgio, P. Russell, P. Pisa, and D. Garland
Interference of Macrophage Migration Inhibitory Factor Expression in a Mouse Melanoma Inhibits Tumor Establishment by Up-Regulating Thrombospondin-1
Mol. Cancer Res., December 1, 2007; 5(12): 1225 - 1231.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. E. Rendon, T. Roger, I. Teneng, M. Zhao, Y. Al-Abed, T. Calandra, and R. A. Mitchell
Regulation of Human Lung Adenocarcinoma Cell Migration and Invasion by Macrophage Migration Inhibitory Factor
J. Biol. Chem., October 12, 2007; 282(41): 29910 - 29918.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. Stein, M. J. Mattes, T. M. Cardillo, H. J. Hansen, C.-H. Chang, J. Burton, S. Govindan, and D. M. Goldenberg
CD74: A New Candidate Target for the Immunotherapy of B-Cell Neoplasms
Clin. Cancer Res., September 15, 2007; 13(18): 5556s - 5563s.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
I. Binsky, M. Haran, D. Starlets, Y. Gore, F. Lantner, N. Harpaz, L. Leng, D. M. Goldenberg, L. Shvidel, A. Berrebi, et al.
IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival
PNAS, August 14, 2007; 104(33): 13408 - 13413.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. V. Crichlow, K. F. Cheng, D. Dabideen, M. Ochani, B. Aljabari, V. A. Pavlov, E. J. Miller, E. Lolis, and Y. Al-Abed
Alternative Chemical Modifications Reverse the Binding Orientation of a Pharmacophore Scaffold in the Active Site of Macrophage Migration Inhibitory Factor
J. Biol. Chem., August 10, 2007; 282(32): 23089 - 23095.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Cho, B. F. Jones, J. J. Vermeire, L. Leng, L. DiFedele, L. M. Harrison, H. Xiong, Y.-K. A. Kwong, Y. Chen, R. Bucala, et al.
Structural and Functional Characterization of a Secreted Hookworm Macrophage Migration Inhibitory Factor (MIF) That Interacts with the Human MIF Receptor CD74
J. Biol. Chem., August 10, 2007; 282(32): 23447 - 23456.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.